Evidence map›Paper›PMID 39815070›Full record

ArticleJournal of cancer research and clinical oncology2025

Impact of

Shunyu Zhang, Minggang Su, Qianrui Li, Qiancheng Hu, Xijiao Liu, Xiaolong Chen, Hongfeng Gou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shunyu Zhang *Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610041, China.
Minggang Su *Department of Nuclear Medicine, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610041, China.
Qianrui LiDepartment of Nuclear Medicine, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610041, China.
Qiancheng HuDepartment of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610041, China.
Xijiao LiuDepartment of Radiology, West China Hospital, Sichuan University, Guoxue Xiang, No. 37, Chengdu, 610041, China.
Xiaolong ChenGastric Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610041, China.
Hongfeng GouDepartment of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, Sichuan, 610041, China. gouhongfeng1977@wchscu.cn.ORCID https://orcid.org/0000-0002-2071-6773

Funding

National Natural Science Foundation of China 72104156the Key R&D Program of Sichuan Provincial Science and Technology 2024YFFK0341
6 · The paper itself

Abstract

purposeTo evaluate the added value of additional

methodsWe retrospectively included patients with gastric cancers who underwent contrast-enhanced computed tomography (ceCT), followed by

resultsWe included 112 patients, 84 for initial staging and 28 for detection of postoperative recurrence. Compared to CT, 29 new findings in 24 patients were diagnosed as, or ruled out, cancer involvement on

conclusions

Indexed as

Gallium RadioisotopesPositron Emission Tomography Computed TomographyStomach NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingQuinolinesRadiopharmaceuticalsRetrospective Studies68Ga-FAPIGallium RadioisotopesQuinolinesRadiopharmaceuticals68Ga-FAPI PET/CTGastric cancerRestagingStagingTherapeutic management

Identifiers

PMID39815070
PMCPMC11735559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.